Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EBT: 2013-2025

Historic EBT for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $8.9 million.

  • Fortress Biotech's EBT rose 133.25% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.8 million, marking a year-over-year increase of 36.72%. This contributed to the annual value of -$120.5 million for FY2024, which is 21.54% up from last year.
  • Per Fortress Biotech's latest filing, its EBT stood at $8.9 million for Q3 2025, which was up 124.69% from -$35.9 million recorded in Q2 2025.
  • Fortress Biotech's EBT's 5-year high stood at $8.9 million during Q3 2025, with a 5-year trough of -$61.9 million in Q4 2021.
  • For the 3-year period, Fortress Biotech's EBT averaged around -$28.3 million, with its median value being -$27.2 million (2024).
  • Per our database at Business Quant, Fortress Biotech's EBT slumped by 157.60% in 2021 and then surged by 133.25% in 2025.
  • Fortress Biotech's EBT (Quarterly) stood at -$61.9 million in 2021, then rose by 7.86% to -$57.0 million in 2022, then spiked by 49.81% to -$28.6 million in 2023, then grew by 9.18% to -$26.0 million in 2024, then soared by 133.25% to $8.9 million in 2025.
  • Its EBT was $8.9 million in Q3 2025, compared to -$35.9 million in Q2 2025 and -$21.8 million in Q1 2025.